Terms: = Ovarian cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253 AND Prognosis
3 results:
1. Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.
Zhao C; Li S; Zhao M; Zhu H; Zhu X
Arch Gynecol Obstet; 2018 Jan; 297(1):153-159. PubMed ID: 29063235
[TBL] [Abstract] [Full Text] [Related]
2. [Hereditary ovarian cancer. The role of BRCA1 gene dysfunction in response to chemotherapy].
Blecharz P; Karolewski K; Urbański K
Ginekol Pol; 2011 Mar; 82(3):214-20. PubMed ID: 21735691
[TBL] [Abstract] [Full Text] [Related]
3. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
Kuschel B; Lux MP; Goecke TO; Beckmann MW
Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
[TBL] [Abstract] [Full Text] [Related]
